default author photo

Wolfgang Galetzka

University of Duisburg-Essen - University Hospital Essen

Hufelandstraße 55

45147 Essen

Germany

SCHOLARLY PAPERS

2

DOWNLOADS

263

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Impact of the Melanocortin-4 Receptor (MC4R) Agonist Setmelanotide, on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Kidney Function in Bardet-Biedl Syndrome

Number of pages: 48 Posted: 26 Dec 2024
University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, Medical University of Vienna - Division of Endocrinology and Metabolism, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen, University of Duisburg-Essen - Department of Pediatrics II and University of Duisburg-Essen - University Hospital Essen
Downloads 221 (345,205)

Abstract:

Loading...

Bardet-Biedl Syndrome, Setmelanotide, Melanocortin-4 Receptor Agonist, Metabolic Dysfunction-Associated Steatotic Liver Disease, Glomerular Filtration Rate

2.

Characterization and Outcome of RAC1 Mutated Melanoma

Number of pages: 24 Posted: 29 Nov 2022
University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, Helios Klinikum Erfurt, University of Lubeck, Heidelberg University - Department of Dermatology, Saarland University - Medical School, Harzklinikum Dorothea Christiane Erxleben, University of Witten/Herdecke - Witten/Herdecke University Hospital, Elbe Kliniken Buxtehude, University Hospital Mühlenkreiskliniken Minden, Dresden University of Technology, Ludwigshafen Medical Center, Schleswig-Holstein University, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen and University of Duisburg-Essen - University Hospital Essen
Downloads 42 (1,157,785)

Abstract:

Loading...

Melanoma, RAC1 mutation, mutational analysis, systemic treatment, immune checkpoint inhi-bition, targeted therapy